| Name: | NX Development Corporation |
| Jurisdiction: | Alaska |
| Legal type: | Business Corporation |
| Status: | Good Standing |
| Date of registration: | 12 Dec 2018 (6 years ago) |
| Entity Number: | 10096037 |
| Place of Formation: | DELAWARE |
| Address: | 870 CORPORATE DRIVE, SUITE 403, LEXINGTON, KY 40507 |
| Mailing Address: | 870 CORPORATE DRIVE, SUITE 403, LEXINGTON, KY 40503 |
Line of Business
31-33 ManufacturingNAICS
325412 PHARMACEUTICAL PREPARATION MANUFACTURING| Name | Role |
|---|---|
| Kenji Hirai | Director |
| Ulrich Kosciessa | Director |
| Motowo Nakajima | Director |
| Salvatore DeSena | Director |
| INCORP SERVICES, INC. | Registered Agent |
| License Number | Type | Status | Issue Date | Date of renewal | Expiration date | Description |
|---|---|---|---|---|---|---|
| 1098959 | Business License | Active | 2018-12-12 | 2024-10-11 | 2026-12-31 | LOB: 31-33 - Manufacturing, NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURING |
| License Number | Program | Type | Status | Issue Date | Effective Date | Expiration Date |
|---|---|---|---|---|---|---|
| 159772 | Pharmacy | Wholesale Drug Distributor | Active | 2020-04-01 | 2024-06-24 | 2026-06-30 |
Date of last update: 24 Jan 2025
Sources: State of Alaska - Department of Commerce, Community, and Economic Development
